The scientists also discovered that muscle strength remained stable across all groups, indicating that weight loss medications may not cause a decline in absolute strength even without exercise ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the improvement of other conditions in longer studies.

In today’s fast-paced world, the struggle with weight management and sluggish energy levels is more common than ever. Many individuals are constantly looking for practical solutions that help them ...

Please provide your email address to receive an email when new articles are posted on . Patients with knee OA treated with semaglutide had significant weight loss and knee OA pain reduction vs.

Please provide your email address to receive an email when new articles are posted on . Wegovy improved exercise function among patients with obesity-related heart failure with preserved ejection ...

Even people who have recovered well from an ischemic stroke may exhibit functional decline after the first six months and for up to five years, according to the findings of a large study (Stroke. 2009 ...